TENAX THERAPEUTICS, INC. Quarterly Common Stock, Shares Authorized from Q1 2011 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Tenax Therapeutics, Inc. quarterly Common Stock, Shares Authorized history and growth rate from Q1 2011 to Q2 2024.
  • Tenax Therapeutics, Inc. Common Stock, Shares Authorized for the quarter ending June 30, 2024 was 400M shares, unchanged year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 400M 0 0% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 400M 0 0% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 400M 0 0% Dec 31, 2023 10-Q 2024-08-13
Q3 2023 400M 0 0% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 400M 0 0% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 400M 0 0% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 400M 0 0% Dec 31, 2022 10-K 2024-03-28
Q3 2022 400M 0 0% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 400M 0 0% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 400M 0 0% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 400M 0 0% Dec 31, 2021 10-K 2023-03-31
Q3 2021 400M 0 0% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 400M 0 0% Jun 30, 2021 10-Q 2021-08-16
Q1 2021 400M 0 0% Mar 31, 2021 10-Q 2021-05-17
Q4 2020 400M 0 0% Dec 31, 2020 10-K 2022-03-29
Q3 2020 400M 0 0% Sep 30, 2020 10-Q 2020-11-16
Q2 2020 400M 0 0% Jun 30, 2020 10-Q 2020-08-14
Q1 2020 400M 0 0% Mar 31, 2020 10-Q 2020-05-15
Q4 2019 400M 0 0% Dec 31, 2019 10-K/A 2021-04-16
Q3 2019 400M 0 0% Sep 30, 2019 10-Q 2019-11-14
Q2 2019 400M 0 0% Jun 30, 2019 10-Q 2019-08-14
Q1 2019 400M 0 0% Mar 31, 2019 10-Q 2019-05-15
Q4 2018 400M 0 0% Dec 31, 2018 10-K 2020-03-30
Q3 2018 400M 0 0% Sep 30, 2018 10-Q 2018-11-14
Q2 2018 400M 0 0% Jun 30, 2018 10-Q 2018-08-14
Q1 2018 400M 0 0% Mar 31, 2018 10-Q 2018-05-15
Q4 2017 400M 0 0% Dec 31, 2017 10-K 2019-04-01
Q3 2017 400M 0 0% Sep 30, 2017 10-Q 2017-11-09
Q2 2017 400M 0 0% Jun 30, 2017 10-Q 2017-08-09
Q1 2017 400M 0 0% Mar 31, 2017 10-Q 2017-05-10
Q4 2016 400M 0 0% Dec 31, 2016 10-K 2018-04-02
Q3 2016 400M 0 0% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 400M 0 0% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 400M 0 0% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 400M 0 0% Dec 31, 2015 10-K 2017-03-16
Q3 2015 400M 0 0% Oct 31, 2015 10-Q 2015-12-10
Q2 2015 400M 0 0% Jul 31, 2015 10-Q 2015-09-09
Q1 2015 400M 0 0% Apr 30, 2015 10-KT 2016-03-14
Q4 2014 400M 0 0% Jan 31, 2015 10-Q 2015-03-17
Q3 2014 400M 0 0% Oct 31, 2014 10-Q 2014-12-15
Q2 2014 400M 0 0% Jul 31, 2014 10-Q 2014-09-15
Q1 2014 400M 0 0% Apr 30, 2014 10-KT 2016-03-14
Q4 2013 400M 0 0% Jan 31, 2014 10-Q 2014-03-17
Q3 2013 400M 0 0% Oct 31, 2013 10-Q 2013-12-17
Q2 2013 400M 0 0% Jul 31, 2013 10-Q 2013-09-17
Q1 2013 400M 0 0% Apr 30, 2013 10-K 2014-07-29
Q4 2012 400M 0 0% Jan 31, 2013 10-Q 2013-03-18
Q3 2012 400M 0 0% Oct 31, 2012 10-Q 2012-12-14
Q2 2012 400M 0 0% Jul 31, 2012 10-Q 2012-09-19
Q1 2012 400M 0 0% Apr 30, 2012 10-K 2013-06-26
Q4 2011 400M Jan 31, 2012 10-Q 2012-03-15
Q3 2011 400M Oct 31, 2011 10-Q 2011-12-15
Q2 2011 400M Jul 31, 2011 10-Q 2011-09-19
Q1 2011 400M Apr 30, 2011 10-K 2012-07-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.